Considering that the absence of an effective therapy for sepsis syndrome, the evidence presented here could be a step forward in understanding the value of leptin administration as an effective therapeutic alternative, which should be confirmed by studies in which leptin is administered after endotoxemia challenge. This evidence concerns the gene LEP and systemic inflammatory response syndrome.